Amrad shareholders stock up

By Melissa Trudinger
Thursday, 22 July, 2004

Some of Amrad's larger shareholders are boosting their holdings in the Melbourne company (ASX:AML), as long-time Japanese investor Chugai divests itself of its 10 per cent stake in the company.

Yesterday the Queensland Investment Corporation -- a major institutional player in Australia's biotechnology sector -- filed documents with the ASX indicating that it had increased its holdings from 5.45 per cent to 10.495 per cent.

And today, the Thorney group, run by multi-millionaire Richard Pratt, said it had raised its stake in the company from 9.14 per cent to 11.88 per cent.

Chugai retains a 2.52 per cent share of the company, making $4.3 million out of the sale of its shares.

The relationship between Amrad and Chugai stretches back 10 years, over which time the Japanese company invested about $20 million into Amrad. But the joint research contract came to a natural end last year when its term expired.

Related News

Lipid science receives new Australia-led online hub

The Lipid Network launched this month to build links between researchers, clinicians and industry...

Proposed Australian trial eyes up blood testing for Alzheimer's

Utilising networks of GPs across three states, a large-scale study intends on combining digital...

Applications open for $300K pandemic therapeutics fellowships

Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd